Home » Tenders » Europe » Germany » Conclusion of Non-exclusive Discount Agreements in Accordance with Section 130a... Tender

Conclusion of Non-exclusive Discount Agreements in Accordance with Section 130a (8)... Tender

Download Documents

AOK RHINELAND-PALATINATE / SAARLAND - THE HEALTH INSURANCE COMPANY has floated a tender for Conclusion of Non-exclusive Discount Agreements in Accordance with Section 130a (8) Sgb V for Pharmaceuticals with the Active Ingredient Valsartan, Amlodipine and Hydrochlorothiazide As Part of a So-called Open-house Model. The project location is Germany and the tender is closing on 31 Aug 2022. The tender notice number is 436848-2020, while the TOT Ref Number is 45867052. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Procurement Summary

Country : Germany

Summary : Conclusion of Non-exclusive Discount Agreements in Accordance with Section 130a (8) Sgb V for Pharmaceuticals with the Active Ingredient Valsartan, Amlodipine and Hydrochlorothiazide As Part of a So-called Open-house Model

Deadline : 31 Aug 2022

Other Information

Notice Type : Tender

TOT Ref.No.: 45867052

Document Ref. No. : 436848-2020

Competition : ICB

Financier : Self Financed

Purchaser Ownership : -

Tender Value : Refer Document

Purchaser's Detail

Purchaser : AOK RHINELAND-PALATINATE / SAARLAND - THE HEALTH INSURANCE COMPANY
Address : Virchowstraße 30
Town : Eisenberg
NUTS-Code : DEB - RHEINLAND-PFALZ
Postal Code : 67304
Phone : +49 6351403203
Germany
Email :am_vertraege@rps.aok.de
URL :www.aok.de/rheinland-pfalz-saarland/

Tender Details

Document Type: Contract notice

Title: Conclusion of non-exclusive discount agreements in accordance with Section 130a, Paragraph 8 of Book V of the Social Code (SGB V) for pharmaceuticals with the active ingredients valsartan, amlodipine and hydrochlorothiazide as part of a so-called open house model
Reference Number: 2020 / S 182-436848

Contract Type: Supplies

Description: Conclusion of non-exclusive discount agreements in accordance with Section 130a (8) SGB V for pharmaceuticals with the active ingredient valsartan, amlodipine and hydrochlorothiazide (C09DX01) within the period from November 1, 2020 to October 31, 2022 with the possibility of concluding a contract at any time (open-house model ).

33600000 - Pharmaceutical products

Authority Type: Body governed by public law

Type of Procedure: Open procedure

Regulation: European Union

Bid Type: Submission for all lots

Doc Title: Pharmaceutical products

Dispatch Date: 2020-09-14

Publish Date: 2020-09-18

Submission Date: 2022-08-31